Sarepta Therapeutics Inc (SRPT)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,527,740 | 1,221,070 | 1,077,070 | 961,192 | 859,337 | 764,357 | 741,411 | 712,749 | 384,950 | 430,840 | 726,457 | 856,886 | 928,009 | 469,528 | 485,108 | 535,445 | 761,759 | 892,047 | 1,042,870 | 1,144,830 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $1,527,740K
= 0.00
The debt-to-equity ratio for Sarepta Therapeutics Inc has consistently been 0.00 for all the reported periods ranging from March 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt financing as a source of capital, preferring to rely on equity financing instead. A debt-to-equity ratio of 0.00 suggests that the company has no debt in its capital structure relative to its equity. While a low debt-to-equity ratio can imply a lower financial risk, it may also mean missed opportunities for leveraging debt for potential growth or tax benefits. Investors and analysts may view a consistently low debt-to-equity ratio as a positive sign of financial stability and conservative financial management.
Peer comparison
Dec 31, 2024